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HEMATOPOIESIS AND STEM CELLS
Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors
and subsequently migrate to inflamed lymph nodes
Michael A. Schmid,1,2 Hitoshi Takizawa,1,2 Dior R. Baumjohann,1 Yasuyuki Saito,2 and Markus G. Manz1,2
1Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland; and 2Division of Hematology, University Hospital Zurich, Zurich, Switzerland
Common dendritic cell progenitors (CDPs)
in the bone marrow (BM) regenerate den-
dritic cells (DCs) in lymphoid and nonlym-
phoid tissues. How the dissemination of
progenitor-derived DCs to peripheral tis-
sues is regulated on need remains elusive.
Microbes are sensed by pathogen recogni-
tion receptors such as Toll-like receptors
(TLRs). We found that CDPs in the BM
express TLR2, TLR4, and TLR9. On TLR
stimulation, CDPs down-regulated CXCR4,
the nonredundant chemokine receptor for
their BM retention, up-regulated CCR7, and
migrated to lymph nodes (LNs). When TLR
agonists were injected locally, CDPs prefer-
entially gave rise to DCs in inflamed LNs in
expense of noninflamed LNs and the BM,
but they did not alter their lineage differentia-
tion and proliferative activity. Consequently,
BM DC progenitors can sense TLR agonists
and, via regulation of CXCR4 and CCR7,
support the replenishment of DCs in reac-
tive LNs. This mechanism likely developed
to support DC homeostasis on specific
need at sites of inflammation. (Blood.
2011;118(18):4829-4840)
Introduction
Dendritic cells (DCs) are the key antigen-presenting cells involved
in both the maintenance of tolerance and induction of immunity.
Multiple subsets of DCs have been identified in lymphoid and
nonlymphoid tissues of which 2 major populations are classic DCs
(cDCs) and plasmacytoid DCs (pDCs).1 cDCs reside within
lymphoid organs and express high levels of CD11c, intermediate
levels of major histocompatibility complex class II (MHC II), and
efficiently present antigen to naive T cells.2 pDCs are located in
lymph nodes (LNs), spleen, BM, and liver; have a spherical shape;
are CD11cint CD45RA; and produce large amounts of type I
interferons on viral infections.3
Most DCs have a short half-life and are continuously replen-
ished from hematopoietic stem and progenitor cells (HSPCs) in the
BM.4,5 Recent studies provide a detailed understanding of the
sequential progenitors that lead to the generation of DCs in steady
state. Macrophage and DC progenitors (MDPs)6 develop into
monocytes, macrophages, and common DC progenitors (CDPs).7,8
CDPs are DC-restricted progenitors,7,9 giving rise to pDCs and
pre-DCs10 that further differentiate to cDCs8 and some nonlym-
phoid tissue DCs.11-13 The key cytokines that drive the generation
of distinct DC subsets in vivo are fms-related tyrosine kinase 3
ligand (Flt3L), granulocyte macrophage–colony stimulating factor
(CSF), and macrophage CSF (M-CSF).1,4,14,15
The migration of differentiated tissue DCs to LNs has been
addressed in multiple studies. In steady state, DCs from peripheral
tissues (such as the skin) travel to draining LNs via afferent
lymphatics, have a CD11cint MHC IIhi phenotype, and are referred
to as migratory DCs (MigDCs).16,17 pDCs, cDCs, and their
progenitors can enter LNs from the blood via high endothelial
venules (HEVs).8,16 For both routes of entry, the chemokine
receptor CCR7 plays a crucial role.17-19 CCR7 is expressed by DCs
and naive/central memory T cells.16 Its ligands CCL21 and CCL19
are present on afferent lymphatics, HEVs, and in the T-cell zones.16
On inflammation, DCs up-regulate CCR720-23 and endothelial cells
increase secretion of CCR7-ligands,19,24 both of which contribute to
increased recruitment of DCs.
In steady state, CDPs reside in the BM and locally give rise to
pDCs and pre-DCs.8,10 Pre-DCs subsequently leave the BM to
generate DCs in nonlymphoid tissues, or they enter LNs via HEVs
in a CD62L-dependent manner.8 HSPCs are retained in the BM by
the chemokine receptor CXCR4 and its ligand CXCL12
(SDF-1),25,26 and the injection of the CXCR4 antagonist AMD3100
leads to mobilization of HSPCs to the blood.27,28 During inflamma-
tion, CXCL12 is down-regulated, and activated neutrophils secrete
proteases that cleave CXCR4 and CXCL12, both inducing the
mobilization of HSPCs from the BM.26,29,30 However, to date little
is known about the migration of BM DC progenitors during
systemic inflammation.
Immune and stroma cells sense pathogen-associated molecular
patterns (PAMPs) of invading microbes via pattern-recognition
receptors.31 Toll-like receptors (TLRs) are pattern-recognition
receptors that are integrated into cellular membranes and detect
exogenous pathogens.31 TLR triggering leads to cell activation and
production of inflammatory cytokines.32 Recent studies indicate
that human33-35 and mouse HSPCs36-38 express TLRs. Once patho-
gens spread from a local site of infection to the blood, they can act
directly on BM cells.38 In fact, systemically injected lipopolysaccha-
ride (LPS) binds to TLR4 on HSPCs in the BM.36 Although the
effects of TLR triggering on mature cells are well defined, little is
known about the biologic relevance of TLR expression on HSPCs.
Recent studies suggest that direct sensing of TLR agonists by
HSPCs may skew their lineage differentiation toward myeloid cells
and DCs.34-36,38 TLR activation of circulating HSPCs was further
suggested to induce a migratory arrest and differentiation at sites of
inflammation.37
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Given these observations, we hypothesized that DC progenitors
in the BM may express TLRs and systemically spreading PAMPs




Sex- and age-matched, 6- to 10-week-old C57BL/6-KA-CD45.1 or
C57BL/6-KA-CD45.2 wild-type (WT) mice were used, if not stated
otherwise. Of these mice, CD45.1xCD45.2 mice in F1 generation were
interbred. CCR7-deficient CD45.2 animals (CCR7/) were provided by
M. Lipp (Max-Delbru¨ck-Center for Molecular Medicine, Berlin, Germany).18
The mice were bred and maintained at the Institute for Research in
Biomedicine, Bellinzona and the University Hospital Zurich animal
facilities, and they were treated in accordance with guidelines of the Swiss
Federal Veterinary Office. The experiments were approved by the Diparti-
mento della sanita` e della socialita` del cantone Ticino and the Gesundheits-
direktion Kanton Zuerich, Veterinaeramt.
Antibodies
All antibodies were purchased from eBiosciences or BioLegend, unless
stated otherwise. The following monoclonal antibodies were used: CD3
(145-2C11), CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD11c
(N418), CD16/CD32 FcR-III/II (2.4G2; BD Biosciences), CD19 (ID3),
CD34 (Ram34), CD45RA (14.8; BD Biosciences), CD45.1 (A20), and
CD45.2 (104) CD44 (IM7; BD Biosciences), CD62L (MEL-14), CCR7
(4B12), CXCR3 (220803; R & D Systems), CXCR4 (2B11), B220
(RA3-6B2), c-kit (2B8), Flt3 (A2F10), Gr-1 (RB6-8C5), IL7R (A7R34),
M-CSFR (AFS98), MHC II (M5/114.15.2; BD Biosciences), NK1.1
(PK136; BD Biosciences), Sca-1 (D7 or E13-161.7; BD Biosciences),
Ter119 (Ter119), TLR2 (6C2), TLR4 (MTS510), and TLR9 (M9.D6). The
antibodies were directly conjugated to fluorochromes, or if biotinylated
they were visualized using fluorochrome-conjugated streptavidin. Cells
were stained in FACS buffer (PBS, 2% FBS, and 2mM EDTA), and for
chemokine- and Toll-like receptors after blocking Fc-receptor binding with
anti-CD16/CD32. For intracellular staining of TLR9, cells were fixed and
permeabilized using the Cytofix/Cytoperm kit (BD Biosciences).
Cell sample preparation
BM samples were prepared as described previously.39 In brief, long bones
and spines were smashed with mortar and pestle, filtered, and density
gradient centrifuged with Histopaque-1077 (Sigma-Aldrich). Spleens and
LNs were mashed and digested for 30 minutes at 37°C with 10 U/mL
DNase-I and 1 mg/mL Collagenase D (Roche Diagnostics). Red blood cells
of spleen and blood samples were lysed in 150mM ammonium chloride and
10mM potassium hydrogen carbonate. Before cell sorting, samples were
immunomagnetically preselected. For BM progenitors, cells positive for
lineage antigens (Lin; CD3, CD4, CD8, CD19, CD11b, B220, Gr-1,
NK1.1, and Ter119) were stained with PE-Cy5–conjugated antibodies,
labeled with anti–Cy5-MicroBeads (Miltenyi Biotec), and negatively
selected with MACS LS-columns and MidiMACS Separators (Miltenyi
Biotec). For spleen or LN DCs, samples were stained with anti–CD11c-
APC, labeled with anti–APC-MicroBeads (Miltenyi Biotec), and enriched
for CD11c. For the analysis of mice that were adoptively transferred with
CDPs, BM and spleen samples were immunomagnetically pre-enriched for
CD11c by staining with CD11c-PECy7 and anti–PE-MicroBeads (Miltenyi
Biotec) to increase the detection of CDP-derived CD11c cells.
FACS and analysis
Cell populations were sorted and analyzed with an FACSAria or FAC-
SCanto2 (both BD Biosciences) according to the following cell surface
phenotypes:4,7,8,39 LSK cells, Lin c-kithi Sca-1; CMP, Lin IL7R c-kithi
Sca-1 CD34 CD16/32lo; granulocyte-macrophage progenitor (GMP),
Lin IL7R c-kithi Sca-1 CD34 CD16/32hi; megakaryocyte-erythro-
cyte progenitor (MEP), Lin IL7R c-kithi Sca-1 CD34 CD16/32lo;
common lymphoid progenitor (CLP), Lin c-kitint Flt3 IL7R; CDP,
Lin c-kitint Flt3 IL7R M-CSFRhi/low; pre-DC, Lin(*) CD11c
MHC II [Lin(*): CD3, CD19, B220, NK1.1, and Ter119]; pDC, CD19
NK1.1 CD11cint CD45RA; and cDC, CD19 NK1.1 CD45RA
CD11chi MHC IIint. From LNs, DC populations were additionally defined as
CD19 NK1.1 CD45RA CD11cint CD40hi MHC IIhi, and CD19
NK1.1 CD45RA CD11chi CD40int MHC IIint. Dead cells were excluded
by propidium iodide staining (Invitrogen). For analysis, 1  106 to 8  106
cells were acquired, and the data were analyzed with the use of FlowJo
Version 9.3.0 software (TreeStar). For the analysis of endogenous CDPs or
pre-DCs, 35 g of TLR agonists (see “In vitro TLR agonist stimulation”)
was injected intravenously, 100 g of AMD3100 (Plerixafor; Genzyme)
was injected subcutaneously. PBS was injected as control, respectively.
Quantitative RT-PCR
Cell populations sorted ex vivo or after culture in vitro were resuspended in
TRIzol-LS reagent (Invitrogen), and RNA was extracted. Remaining DNA
was eliminated by DNase I treatment using the DNA-free kit (Applied
Biosystems). For cDNA synthesis equal amounts of RNA were reverse
transcribed using SuperScript-III (Invitrogen). Quantitative real-time PCR
was performed on a 7900HT Fast System (Applied Biosystems) using
TaqMan primers and probes for Rn18s (Hs99999901_s1), Tlr2
(Mm00442346_m1), Tlr4 (Mm00445274_m1), Tlr9 (Mm0046193_m1),
Cxcr4 (Mm01292123_m1), and Ccr7 (Mm00432608_m1). Results were
normalized to Rn18s.
In vitro TLR agonist stimulation
FACS-sorted CDPs were cultured in RPMI 1640 (Invitrogen) supplemented
with 10% FBS (Invitrogen), 2% penicillin-streptomycin (Invitrogen),
GlutaMAX (Invitrogen), 50 ng/mL mouse Flt3L, 10 ng/mL SCF, and
20 ng/mL M-CSF (R&D Systems) and stimulated for 12 and 21 hours with
10 g/mL Pam3csk4 (InvivoGen), 10 g/mL ultrapure LPS from
Escherichia coli 0111:B4 (InvivoGen), or 5 g/mL CpG-ODN1826
(Microsynth). In some experiments, CDPs were stimulated with Pam3csk4
or CpG for 2 hours in vitro in medium containing 50 ng/mL mouse Flt3L,
and the cells were subsequently transferred in vivo as indicated.
In vivo adoptive transfer assays
CDPs (2-3  105) were isolated by FACS from the BM of female CD45.1,
CD45.2 WT, or CD45.2 CCR7/ mice. The cells were labeled for
8 minutes with 2M CFSE at 37°C and adoptively transferred intrave-
nously into 3-week-old CD45.1xCD45.2 female F1 nonirradiated hosts. In
some experiments, 25 g of CpG or PBS was subcutaneously injected into
one of the front foot pads immediately after adoptive transfer of the cells. In
this case, brachial and axillary LNs from the injected and the noninjected
side were analyzed. For the analysis of mice that were adoptively
transferred with CDPs, BM and spleen samples were enriched for CD11c to
increase the detection of CD11c DC-offspring. In addition to the enriched
samples, nonenriched samples were acquired by flow cytometry to assess
CD11c CDP-offspring (data not shown). For samples from subcutaneous
LNs, total cells from the LNs were acquired without prior enrichment.
Statistics
The data were analyzed for statistical significance with the use of 2-tailed,
unpaired t tests using Prism 4 software (GraphPad Software). P was
considered significant at values .05.
Results
CDP express TLR2, TLR4, and TLR9
We used quantitative real-time PCR to assess the Tlr mRNA expression
in CDPs. CDPs expressed relatively high levels of Tlr2, that is, within
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the range of splenic DCs, and	 3-fold higher than other BM progeni-
tors (Figure 1A). CDPs expressed moderate levels of Tlr4, at magni-
tudes similar to CMPs and CLPs, but less than LSK cells, GMPs, or
splenic DCs (Figure 1B). CDPs expressed intermediate levels of Tlr7,
similar to LSK cells, and higher than CMPs and GMPs, but lower than
CLPs, or splenic DCs (data not shown). CDPs expressed relatively high
levels of Tlr9, 2-fold higher than CLPs, and more than 10-fold higher
than other BM progenitors, but lower than splenic DCs (Figure 1C). On
the protein level, CDPs in the BM expressed relative high amounts of
surface TLR2 and intracellular TLR9, at levels comparable to spleen
pDC and cDCs (Figure 1D). Furthermore, CDPs expressed low TLR4
surface protein, at levels similar to pDCs, and cDCs express intermedi-
ate levels of TLR4. The TLR protein expression of pre-DCs and other
hematopoietic progenitor cells in the BM is shown in supplemental
Figure 1 (available on the Blood Web site; see the Supplemental
Materials link at the top of the online article). Interestingly, pre-DCs, the
immediate progeny of CDPs, expressed relatively high levels of TLR2
and TLR9 protein, comparable to CDPs, and low levels of TLR4. In
conclusion, CDPs express high levels of TLR2 and TLR9 and interme-
diate levels of TLR4, both for mRNA and protein.
Chemokine receptor and migratory marker expression by CDPs
Because triggering of the expressed TLRs may influence their
migratory behavior, we examined the chemokine receptor expres-
sion of CDPs in steady state. Compared with DCs isolated from
LNs, CDPs in the BM expressed relatively high levels of Cxcr4
mRNA and protein (Figure 2A-B). In contrast, CDPs expressed
low levels of Ccr7 mRNA, just above the limit of detection (Figure
2C), and no surface protein (Figure 2D). The expression of Ccr7
mRNA and protein was the highest for CD11cint MHC IIhi DCs,
whereas CD11chi MHC IIint DCs and pDCs expressed intermediate
to low levels. Furthermore, CDPs express CD62L and CD44, but
they were negative for CXCR3 and CD11c (see Onai et al7; data not
Figure 1. CDPs express TLR2, TLR4, and TLR9. The relative mRNA expression of Tlr2 (A), Tlr4 (B), and Tlr9 (C) is shown for progenitor populations (dark gray) and CDPs
(blue) sorted from steady-state mouse BM, and pDCs and cDCs from the spleen (light gray). Progenitors included LSK cells containing stem cells and multipotent progenitors,
CMP,46 GMP, MEP, and CLP.47 Populations were isolated by FACS, mRNA expression was determined by quantitative real-time PCR, and levels were normalized to Rn18s.
Results on mRNA show means and SEM of 4 independent experiments, including independent cell sorts and real-time PCR runs, and they are plotted on a bilogarithmic scale
(log 2). Histograms show surface TLR2 and TLR4 protein expression, and intracellular expression of TLR9 (gray filled histograms), overlaid with isotype-matched control stains
(black line) of BM CDPs and spleen pDCs and cDCs (D). The data show 1 representative experiment of 3 independent experiments.
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shown). Therefore, CDPs in steady state display a migratory
marker profile typical of BM-resident HSPCs, such as CXCR4 and
CD44, but they do not express markers of differentiated DCs, such
as CCR7 or CXCR3.16
TLR-stimulated CDPs down-regulate CXCR4 and up-regulate
CCR7
To investigate the biologic relevance of TLR expression by CDPs,
we stimulated CDPs with TLR agonists in vitro. Synthetic triacy-
lated lipoprotein Pam3csk4 was used to stimulate TLR2, LPS was
used for TLR4, and unmethylated CpG-containing oligodeoxynucle-
otides (CpG) was used for TLR9. After 12 hours, Pam3csk4 or CpG
led to a strong down-regulation of Cxcr4 mRNA (Figure 3A) and
up-regulation of Ccr7 (Figure 3D). Similar but less pronounced
effects were induced by LPS. In line with mRNA expression,
CXCR4 surface protein was down-regulated 21 hours after stimula-
tion with all TLR agonists used (Figure 3B-C), and CCR7 protein
was up-regulated after stimulation with Pam3csk4 and CpG, but
only minor effects were observed for LPS (Figure 3E-F). The
mRNA expression of transcription factors relevant for DC develop-
ment (Stat3, Sfpi1, Spib, and Cebpa) and cytokine receptors (Flt3
and Csf2ra) changed no more than 3-fold on stimulation of CDPs
with TLR agonists (data not shown). We thus conclude that the
direct triggering of TLRs on CDPs induces a change in their
chemokine receptor expression, that is, down-regulation of CXCR4
and up-regulation of CCR7.
TLRs regulate CDP-migration in vivo
Our results on changes in the chemokine receptor profile of CDPs
imply that TLR triggers may directly regulate their migration. We
Figure 2. CDPs express CXCR4 but no detectable levels of CCR7. The expression of the chemokine receptors Cxcr4 (A-B) and Ccr7 (C-D) was determined for CDPs that
were isolated by FACS from steady-state BM and for indicated DCs from subcutaneous LNs. Bar graphs show Cxcr4 (A) and Ccr7 (C) mRNA expression of CDPs (blue), pDCs,
CD11cint MHC IIhi DCs, and CD11chi MHC IIint DCs (gray). mRNA expression was assessed by quantitative real-time PCR and normalized to Rn18s. Histogram overlays show
surface protein expression of CXCR4 (B) and CCR7 (D) evaluated by flow cytometry. Specific antibody stains are shown in filled blue histograms, and isotype-matched controls
are shown in dotted lines. Bar graphs show means and SEM of 3 independent experiments, including independent cell sorts and real-time PCR runs (A,C), and histograms
show 1 representative experiment (B,D) of 3 independent experiments.
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tested this hypothesis in vivo by adoptively cotransferring in vitro
TLR-stimulated and nonstimulated CDPs into steady-state recipi-
ents. CD45.1 CDPs were stimulated with CpG for 2 hours in
cultures containing Flt3L and mixed in a one-to-one ratio with
CD45.2 CDPs from control cultures containing only Flt3L
(Figure 4A). The mix of CDPs was then labeled with CFSE and
adoptively transferred into steady-state, nonirradiated
CD45.1xCD45.2 F1 hosts. Thirty hours after the transfer, the
recipient’s BM contained only 35.3% CpG-stimulated but 63.7%
nonstimulated CDP-derived cells (Figure 4B). Equal numbers of
both populations were found in the spleen. In subcutaneous LNs,
74.1% of the engrafted cells were derived from CpG-stimulated
CDPs and only 20.5% from nonstimulated CDPs. Most CDP-
derived cells in the BM, spleen, and LNs showed a CD11c MHC
IIint phenotype of developing DCs, whereas some cells in the BM
and spleen were CD11c MHC II, characteristic for pre-DCs.10
All cells were negative to intermediate for CD45RA, and no
CD11c CDP-derived cells were detectable in any of the analyzed
organs. Furthermore, no clear difference in the phenotype of
stimulated and nonstimulated cells was observed with the majority
of cells showing a CD11c MHC IIint phenotype (Figure 4B). The
in vitro stimulation of CDPs with Pam3csk4 led to similar effects,
although not as pronounced as those observed after CpG stimula-
tion (supplemental Figure 2). These results for the first time
Figure 3. CDPs down-regulate CXCR4 and up-regulate CCR7 on TLR stimulation in vitro. FACS-isolated CDPs were cultured in cytokines alone (control) or stimulated by
adding the TLR agonists Pam3csk4, LPS, or CpG. Twelve hours later, mRNA was isolated, and chemokine receptor expression was assessed by quantitative real-time PCR
and normalized to Rn18s. Bar graphs show relative expression of mRNA for Cxcr4 (A) and Ccr7 (D) in cultures with cytokines alone (gray) or after addition of TLR agonists
(red). Surface protein expression was determined by flow cytometry after 21 hours. Histograms show protein surface expression (blue filled) of CXCR4 (B) and
CCR7 (E), overlaid with isotype-matched controls (dotted lines). The relative quantification of protein expression as a ratio between the mean fluorescence intensity of the
specific antibody stain and isotype-matched controls is shown for CXCR4 (C) and CCR7 (F). mRNA expression is shown as means and SEM of 4 (A) or 5 (D) independent
experiments, including independent cell sorts, cultures, and real-time PCR runs. The fold-changed mRNA expression and the level of statistical significant difference between
stimulated cells and control cultures is indicated on the graphs. The histogram overlays (B,E) and the quantification of changes in protein expression (C,F) are shown as
1 representative experiment of 2 independent experiments.
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demonstrate that TLR triggering of bone marrow CDPs can directly
regulate their migration, that is, their preferential homing to LNs.
In contrast, we did not observe that TLR triggering had major
effects on the differentiation of distinct DC subtypes from CDPs.
Retention of CDPs in BM depends on CXCR4
We next investigated whether steady-state expressed CXCR4 is
important for the retention of CDPs in the BM. Because a genetic
Figure 4. TLR-stimulated CDPs preferentially home to LNs in expense of the BM in steady-state hosts. CDPs were FACS-isolated from the BM of CD45.1 and CD45.2
mice. CD45.1 CDPs were stimulated for 2 hours in cultures containing Flt3L and CpG, whereas CD45.2 CDPs were cultured in Flt3L alone. After culture, CDPs were
washed, mixed in a one-to-one ratio, CFSE-labeled, and adoptively transferred intravenously into CD45.1xCD45.2 F1 steady-state hosts. After 30 hours, BM, spleen, and
subcutaneous LNs were analyzed. The transferred mix of CD45.1 CpG-stimulated CDPs and CD45.2 CDPs from control cultures is shown in panel A. Cells gated on NK1.1
CD19 are shown for the different organs after 30 hours in vivo (B left column). To better distinguish CDP-derived cells from the host, cells were gated CFSE, and the ratio of
CD45.1 CpG-stimulated and CD45.2-nonstimulated cells was determined (B middle column). The CD11c and MHC II expression of CD45RA cells is shown for each subset
(B right column). The results of 1 representative experiment of 3 independent experiments of each recipient mouse are shown.
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deletion of Cxcr4 is lethal in mice,26 we used the Cxcr4 antagonist
AMD3100 to assess this question. In steady state, no or very few
CDPs were detectable outside the BM, such as in the blood, spleen,
or LNs (PBS control; Figure 5A-D; supplemental Figure 3). In
contrast, 1 hour after injection of AMD3100, there was a transient
decrease in CDP numbers in the BM that was not significant, given
the broad range of CDP numbers in individual animals and the
amount of animals analyzed. Nevertheless, CDPs increased signifi-
cantly after 1 hour in the blood and spleen, and CDPs were
significantly increased in the spleen and LNs 4 hours afterAMD3100
application. Of note, the increase in total numbers of CDPs in
blood, spleen, and LNs correlated well with temporary decrease of
CDPs in BM, with overall low absolute numbers of CDPs in the
periphery (range,  1000-30 000) compared with relatively high
numbers in BM (range, 70 000-220 000). Because CDPs cannot be
detected at relevant numbers in any other tissue than BM in steady
state, the CDPs appearing in the periphery on injection of
AMD3100 must have exited the BM, and the BM localization of
these CDPs thus depended on CXCR4. In addition, the number of
Lin(*) CD11c MHC II pre-DCs8,10 decreased significantly in
the BM after 4 hours of AMD3100 injection and increased in the
blood and spleen after 1 and 4 hours (supplemental Figure 4),
further supporting the finding that the localization of DC progeni-
tors in the BM depends on CXCR4.
Figure 5. DC progenitor mobilization from the BM.
CXCR4 antagonist AMD3100 or PBS were injected sub-
cutaneously. The absolute number of CDPs was as-
sessed by flow cytometry, 1 hour after injection of PBS,
and 1 and 4 hours after injection of AMD3100. The results
for BM (A; n.s. indicates not significant), blood (B), spleen
(C), and subcutaneous LNs (D) of 6 independent experi-
ments using a total of 7 to 9 mice (1 filled square per
mouse) per condition are shown. CDPs were gated as
Lin c-kitint Flt3 M-CSFR IL7R CD11c MHC II.
Mean values are depicted (horizontal lines), and where
significant, the levels of significant difference between
PBS-injected controls and AMD3100-injected animals
are indicated. TLR agonists were injected intravenously,
and the numbers of Lin(*) CD11c MHC II cells,
corresponding to pre-DCs, were assessed by flow cytom-
etry after 12 hours in the BM (E) and blood (F). The total
number of pre-DCs is indicated for each individual ani-
mal. The data from 2 independent experiments using a
total of 5 mice per condition are shown. Mean values are
depicted (horizontal lines), and where significant, the
levels of significant difference between PBS- and TLR
agonist-injected animals are indicated.
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DC progenitors are mobilized from the BM on injection of TLR
agonists
Based on the finding that TLR-stimulated CDPs down-regulate
CXCR4, we hypothesized that TLR triggering would mobilize
CDPs from the BM. To test this hypothesis, we injected TLR
agonists intravenously or into the foot pad and tried to assess the
numbers of CDPs in BM, blood, spleen, and LNs. However, cells
expressing Flt3 and M-CSFR, that is, cells with the defined
phenotype of CDPs, were not detectable in BM and any of the
organs after 12 and 24 hours (data not shown). This was probably
because of increased levels of respective cytokines, leading to
internalization of the receptors,40 blockage of antibody binding, or
both. In contrast to CDPs, pre-DCs, containing immediate down-
stream CDP progeny, could be monitored by surface phenotype and
were significantly reduced in the BM and increased in the blood
12 hours after injection of TLR agonists (Figure 5E-F). Thus, CDPs
that sense TLR agonists in vivo and down-regulate CXCR4 are
probably consecutively mobilized from the BM, although, because
of technical limitations caused by the induced inflammation, this
currently is only directly demonstrated for their immediate prog-
eny, pre-DCs.
CDP-derived DCs are recruited to inflamed LNs
We next addressed the question of how TLR agonists may influence
the differentiation of CDPs and the localization of CDP-derived
DCs in vivo. Freshly isolated CDPs were adoptively transferred
into nonirradiated hosts and at the same time CpG was injected into
the foot pad. By day 4, CDPs, on average, gave rise to 3.3-fold
more pDCs, 26.8-fold more CD11cint MHC IIhi DCs, and 8.4-fold
more CD11chi MHC IIint DCs in inflamed LNs draining the
CpG-injected side compared with LNs from the noninjected side of
an animal (Figure 6A-B). DC subsets derived from transferred
CDPs and of host origin were gated similarly (supplemental Figure
5). Adoptively transferred CDPs gave rise to substantial numbers of
pDCs and cDCs in the BM and spleen on day 4, with similar
pDC-to-cDC ratios in mice injected with CpG or PBS (data not
shown). However, the engraftment of pDCs into the LNs was
generally low. No cells of other lineages than DCs were observed in
any of the TLR agonist–treated or steady-state animals. The
injection of Pam3csk4 into the foot pad led to a similar recruitment
of CDP-derived DCs into LNs draining the site of injection as CpG
(data not shown), whereas PBS did not have any effect (Figure 6B;
supplemental Figure 5). There was no difference in the prolifera-
tion activity of CDP-derived cells from inflamed and control LNs
of the same animal, as determined by CFSE dilution (Figure 6A).
Together, these data indicate that the local administration of TLR
agonists leads to a significant increase of CDP-derived CD11cint
MHC IIhi and CD11chi MHC IIint DCs in inflamed LNs, which was
because of recruitment but not to increased local proliferation.
Interestingly, the increase in CDP-derived DCs in inflamed LNs
was higher than the increase in total cells within these LNs,
suggesting an active migration of CDP-derived progenitors, DCs,
or both to inflamed LNs, rather than a passive increase in their
numbers with the total LN size. In addition, we detected a 2.8-fold
decrease in CDP-derived DCs in the BM of animals that were
injected with CpG into the foot pad, compared with animals treated
with PBS (Figure 6C). This further supports the hypothesis that
locally injected TLR agonists spread to the BM and lead to the
mobilization of CDPs.
CCR7 contributes to the generation of LN DCs from CDPs
Finally, we investigated the role of CCR7 in TLR-mediated
recruitment of CDP-derived DCs to inflamed LNs. A one-to-one
mix of freshly isolated CD45.1 WT and CD45.2 CCR7-deficient
(CCR7/) CDPs was transferred into CD45.1xCD45.2 F1 hosts,
and CpG was injected into one foot pad. In the representative
experiment shown, 48.3% WT and 51.2% CCR7/ CDPs were
transferred (Figure 7A). As in previous experiments, the transferred
CDPs gave rise to increased numbers of DCs in the LNs on the
inflamed side by day 4 (Figure 7B). Of these, 76.3% derived from
WT and only 21.9% from CCR7/ CDPs. In LNs from the
noninflamed side (Figure 7B) or LNs from PBS-treated animals
(supplemental Figure 6), the few CDP-derived cells that were
detected consisted of 	 80% WT and 20% CCR7/ cells. In
contrast, WT and CCR7/ CDPs engrafted equally well into the
BM of CpG- and PBS-treated animals (supplemental Figure 6).
Because the total engraftment of pDCs in the LNs on day 4 was
very low, they were excluded from further analysis. CD11cint MHC
IIhi DCs in inflamed LNs were derived from 94.3% of WT and
5.7% of CCR7/ CDPs, whereas CD11chi MHC IIint DCs derived
from 69.5% of WT and 30.5% of CCR7/ CDPs (Figure 7C). In
conclusion, CCR7 on CDPs is up-regulated by TLR agonists and
CCR7 is essential for the recruitment of CDP-derived CD11cint
MHC IIhi DCs to inflamed LNs, whereas CCR7 independent,
partially compensatory recruitment mechanisms exist for CD11chi
MHC IIint CDP-derived DCs, because this population was reduced
by approximately half.
Discussion
Invading infectious pathogens are sensed by immune cells
carrying pathogen recognition receptors, such as TLRs. TLR
triggering of DCs leads to their cellular activation, ie, migration,
antigen processing and presentation, secretion of inflammatory
cytokines, and ultimately the induction of innate and adaptive
immune responses. Here, we asked the question whether
pathogen recognition is restricted to mature DCs or whether
pathogens can already be detected by early DC-restricted
hematopoietic progenitors in the BM, and if so, what would be
the impact of such recognition?
We found that CDPs,7,9 the earliest DC-restricted progenitors in
the BM, indeed express high levels of TLR2 and TLR9 and
moderate levels of TLR4 and TLR7 compared with other HSPCs.36,38
On in vitro stimulation of TLRs, CDPs drastically changed their
chemokine receptor profile: CXCR4, a receptor we here found to
be important for CDP retention in the BM, was down-regulated and
CCR7, a receptor critical for LN homing, was up-regulated. As a
consequence, CDPs altered their migratory behavior in vivo and
generated increased numbers of DCs in inflamed LNs at the
expense of DC generation in the BM. Such bias was because of
preferential homing of CDP-derived DCs to inflammatory sites and
not a result of local proliferation. We thus propose a novel
mechanism of DC regeneration in inflamed LNs initiated by the
exposure of BM DC-restricted progenitors to systemically spread-
ing pathogen-associated signals.
Previous studies demonstrated that PAMPs spreading from a
local source of infection can reach the BM, where they are
sensed via TLRs by HSPCs. Nagai et al showed that HSPCs,
such as LSK cells and GMPs express relatively high levels of
TLR2 and TLR4, and 1 hour after intravenous or intraperitoneal
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injection, LPS was bound to TLR4 on the surface of HSPCs in
the BM.36 On direct stimulation of TLR2, TLR4, and TLR7/8,
multipotent HSPCs, CMPs, and GMPs differentiated to monocytes,
macrophages, and DCs at the expense of other lineages.34-36,38,41
CLPs further expressed particularly high TLR9, and corneal infection
with herpes simplex virus-1 led to preferential differentiation of CLPs to
DCs at the cost of lymphoid development.38 These findings imply that
TLR ligation on upstream progenitor cells would skew their differentia-
tion toward needed cellular components. Here, we confirm the TLR
expression pattern of early hematopoietic progenitors.36,38 However, in
contrast to previous studies on other hematopoietic progenitors as
myeloid progenitors and CLP, we did not observe substantial changes in
the differentiation of CDPs in vivo. In both steady state and on injection
of CpG, adoptively transferred CDPs gave rise to a similar ratio of pDCs
and cDCs in the BM and spleen of nonirradiated recipients, and they did
not generate cells of other lineages. Consequently, although TLR-
induced lineage skewing might be relevant for upstream progenitors that
carry the potential for multiple lineage development, this effect was not
observed for DC-restricted progenitors in steady state and during
inflammation.
Figure 6. CDPs give rise to increased numbers of DCs in inflamed LNs. CD45.1xCD45.2 F1 hosts were transplanted with freshly isolated, CFSE-labeled CD45.1 CDPs
and injected with either 25 g of CpG or PBS into one foot pad. The plots show CD19 NK1.1 cells on day 4 in LNs draining the injected side and the noninjected side of a
representative CpG-treated animal (A). The cells were first gated CFSE to separate transferred CDP-derived cells from the host background (left) and further gated CD45.1
CD45.2 cells (data not shown). The gating for pDCs (CD11clow CD45RA), CD11cint MHC IIhi, and CD11chi MHC IIint DCs derived from transferred CDPs is indicated (middle to
right). The bar graph in panel B shows the average number of CDP-derived cells in the LNs from the injected and the noninjected side of animals treated with CpG or PBS. The
numbers drawn on the graph indicate the average fold increase of CDP-derived DCs on the injected compared with the noninjected side. The number of total CDP-derived cells
in the BM of PBS- and CpG-treated animals it shown in panel C. The graphs show the means and SEM of 4 independent experiments, each using 1 CpG- and 1 PBS-treated
recipient mouse, and the level of significant difference between inflamed and noninflamed organs is indicated.
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Thus far, only one previous study investigated the migration
of HSPCs on TLR triggering. Massberg et al examined a
population of LSK cells that in steady state circulates through
the blood, peripheral tissues, and the lymph.37 On LPS stimula-
tion in vitro and subsequent retransfer in vivo, these cells ceased
to migrate and down-regulated sphingosine 1-phosphate recep-
tor S1P1, normally controlling the egress of lymphocytes from
the tissue into the lymphatics, and they differentiated locally
into myelomonocytic cells. The expression of chemokine recep-
tors was not examined in this study. In contrast to circulating
LSK cells, we and others have shown that CDPs in steady state
reside in the BM and are not detectable in the blood, spleen, or
Figure 7. LN recruitment of CDP-derived DCs depends on
CCR7. Freshly isolated CDPs from CD45.1 WT and CD45.2
CCR7-deficient animals (CCR7/) were mixed in a one-to-one
ratio, CFSE-labeled, and adoptively transferred intravenously into
CD45.1xCD45.2 F1 hosts that were injected with 25 g of CpG into
the foot pad. The transferred mix of CD45.1 WT and CD45.2
CCR7/ CDPs of 1 representative experiment is shown in panel A.
Plots in panel B show CD19 NK1.1 cells from LNs of the
CpG-injected and the noninjected side on day 4. The samples were
further gated CFSE to assess the ratio of CD45.1 WT and
CD45.2 CCR7/ CDP-derived cells. The bar graph in panel C
indicates the percentage of CD11cint MHC IIhi or CD11chi MHC IIint
DCs derived from WT or CCR7/ CDPs. The transferred CDP-mix
of 50% WT and 50% CCR7/ is indicated by a dotted line. One of
3 independent experiments is depicted using one recipient animal
per condition (A-B). The bar graph in panel C shows the mean and
SEM of the 3 independent experiments with indication of the level
of significant differences between WT and CCR7/ DC subsets.
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LNs.8 Therefore, CDPs should only encounter TLR agonists that
spread systemically to the BM. In this study, we found that CDP
retention in the BM relies on CXCR4 and that CXCR4 is
down-regulated by CDPs on direct stimulation with TLR
agonists. Moreover, adoptively transferred CDPs gave rise to
less DCs in the BM on injection of CpG than in steady state.
Because CDPs are identified by the cytokine receptors Flt3 and
M-CSFR, this population cannot be monitored directly once the
respective cytokines are elevated on inflammation. However, an
immediate progeny of CDPs, pre-DCs, decreased in the BM and
increased in the blood on intravenous injection of TLR agonists,
and the localization of pre-DCs in the BM depended on CXCR4.
These findings strongly support the view that PAMPs spreading
from a source of infection and reaching the BM lead to a
mobilization of DC progenitors via down-regulation of CXCR4.
This progenitor cell intrinsic mechanism complements and
synergizes with the previous finding that BM stroma cells
decrease the production of CXCL12 and activated neutrophils
secrete proteases that cleave CXCL12 and CXCR4 on inflamma-
tory stimuli, such as LPS, further contributing to the release of
progenitors from the BM.29,42
In steady state, pre-DCs circulate in the blood and enter LNs via
HEVs to locally generate cDCs.8 Pre-DCs further give rise to DCs
in nonlymphoid tissues,11-13 which subsequently may enter afferent
lymphatics and reach LNs as MigDCs.16,17 In steady-state LNs,
cDCs are CD11chi MHC IIint (similar to cDCs in the spleen),
whereas MigDCs are considered to be CD11cint MHC IIhi.8,16,17
Activated DCs also up-regulate MHC II,2 and whether conclusions
on the migratory origin of DCs can be drawn from their phenotype
in inflamed LNs remains to be determined. Here, we demonstrate
that CDPs mobilized via the injection of AMD3100 increase in LNs
after only 4 hours. In addition, TLR-stimulated CDPs efficiently
migrated to LNs and gave rise to increased numbers of CD11c
MHC IIint DCs 30 hours after adoptive transfer, whereas nonstimu-
lated CDPs preferentially homed to the BM in the same steady-
state recipient.
CD62L is expressed on steady-state CDPs, is essential for the
rolling of lymphocytes on HEVs,43 and was demonstrated to be
important for the entry of pre-DCs into LNs.8 On stimulation with
TLR agonists, we found that CDPs drastically up-regulated CCR7.
The recruitment of CDP-derived CD11cint MHC IIhi and CD11chi
MHC IIint depended significantly on CCR7 on subcutaneous
injection of CpG. This indicates that the TLR-induced up-
regulation of CCR7 is relevant for the recruitment of both subsets
of DCs or their progenitors to inflamed LNs. However, some
CD11chi MHC IIint DCs were recruited in the absence of CCR7,
when WT and CCR7/ CDPs were competitively transferred. In
line with our results, it has been demonstrated previously that
CD11cint MHC IIhi DCs express higher levels of CCR7 compared
with CD11chi MHC IIint DCs and that their migration is more
dependent on faithful expression of CCR7.17 CCR7 ligands were
further shown to be up-regulated by LN epithelial cells on
inflammation,19,24 probably synergizing with the up-regulation of
CCR7 on CDPs.
Recently, monocytes were shown to enter inflamed LNs from
the blood on injection of TLR4 agonist LPS or E coli in a CD62L-
and CCR7-dependent manner and to give rise to monocyte-derived
DCs that efficiently primed T-cell responses.44,45 Here, we report a
CCR7-dependent recruitment of CDP-derived DCs to inflamed
LNs, that is, a differentiation pathway that is independent of
monocytes.4,5 The effects we observed were induced via triggering
of TLR2 and TLR9, whereas TLR4 stimulation led to less strong
effects. Different classes of pathogens may thus lead to the
recruitment of DCs from different sources. The expressed TLRs
enable CDPs to sense components from the cell wall of gram-
positive bacteria and lipoproteins from enveloped viruses via
TLR2, LPS from the outer membrane of gram-negative bacteria via
TLR4, and DNA from bacteria and DNA viruses via TLR9.31 We
stimulated CDPs with purified TLR agonists and observed differ-
ences only in the strength of the response. During bacterial or viral
infections, several TLRs are triggered in parallel and may induce
synergistic effects. DCs that enter reactive LNs from infected
tissues and LN-resident DCs should be the first antigen-presenting
cells to prime naive T cells, followed by monocyte-derived DCs. In
contrast, the recruitment of DC progenitors probably plays a role in
DC replenishment.
In conclusion, we present the first report that the earliest BM
DC-restricted progenitors, CDPs, express functional TLRs that
regulate their chemokine receptor expression and their migratory
behavior in vivo. In a physiologic context, once PAMPs from a
spreading microbial infection reach the BM, CDPs are mobilized
via down-regulation of CXCR4 and their offspring are recruited to
inflamed LNs via up-regulation of CCR7. We speculate that this
mechanism has evolved to sustain adequate numbers of DCs in
reactive LNs during ongoing immune responses and to restore DC
homeostasis once the inflammation has ceased.
Acknowledgments
The authors thank David Jarrossay for cell sorting and Enrica Mira
Cato`, Andrea D’Ercole, Luana Perlini, Emanuele Cavadini, Walter
Ettlin, and Gregor Kuenzi for animal care.
This work was supported by the Swiss National Science
Foundation (grant 310030-116637, M.G.M.) and the DC-THERA
European network “Dendritic cells and Novel Therapies”
(M.G.M.).
Authorship
Contribution: M.A.S. designed and performed experiments, ana-
lyzed and interpreted data, and wrote the manuscript; H.T. designed
and both H.T. and D.R.B. performed experiments, discussed data,
and edited the manuscript; Y.S. performed experiments; and
M.G.M. directed the study.
Conflict-of-interest disclosure: The authors declare no compet-
ing financial interests.
Correspondence: Markus G. Manz, Division of Hematology,
University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Swit-
zerland; e-mail: markus.manz@usz.ch.
References
1. Merad M, Manz MG. Dendritic cell homeostasis.
Blood. 2009;113(15):3418-3427.
2. Banchereau J, Steinman RM. Dendritic cells and the
control of immunity. Nature. 1998;392(6673):245-252.
3. Liu YJIPC: professional type 1 interferon-producing
cells and plasmacytoid dendritic cell precursors.
Annu Rev Immunol. 2005;23:275-306.
4. Schmid MA, Kingston D, Boddupalli S, Manz MG.
Instructive cytokine signals in dendritic cell lin-
eage commitment. Immunol Rev. 2010;234(1):
32-44.
5. Geissmann F, Manz MG, Jung S, Sieweke MH,
TLR-MEDIATED DENDRITIC CELL PROGENITOR MIGRATION 4839BLOOD, 3 NOVEMBER 2011  VOLUME 118, NUMBER 18  only.
For personal use at UNIVERSITAETSSPITAL on November 25, 2011. bloodjournal.hematologylibrary.orgFrom 
Merad M, Ley K. Development of monocytes,
macrophages, and dendritic cells. Science. 2010;
327(5966):656-661.
6. Fogg DK, Sibon C, Miled C, et al. A clonogenic
bone marrow progenitor specific for macro-
phages and dendritic cells. Science. 2006;
311(5757):83-87.
7. Onai N, Obata-Onai A, Schmid MA, Ohteki T,
Jarrossay D, Manz MG. Identification of clonogenic
common Flt3M-CSFR plasmacytoid and con-
ventional dendritic cell progenitors in mouse bone
marrow. Nat Immunol. 2007;8(11):1207-1216.
8. Liu K, Victora GD, Schwickert TA, et al. In vivo
analysis of dendritic cell development and ho-
meostasis. Science. 2009;324(5925):392-397.
9. Naik SH, Sathe P, Park HY, et al. Development of
plasmacytoid and conventional dendritic cell sub-
types from single precursor cells derived in vitro
and in vivo. Nat Immunol. 2007;8(11):1217-1226.
10. Naik SH, Metcalf D, van Nieuwenhuijze A, et al.
Intrasplenic steady-state dendritic cell precursors
that are distinct from monocytes. Nat Immunol.
2006;7(6):663-671.
11. Bogunovic M, Ginhoux F, Helft J, et al. Origin of
the lamina propria dendritic cell network. Immu-
nity. 2009;31(3):513-25.
12. Varol C, Vallon-Eberhard A, Elinav E, et al. Intesti-
nal lamina propria dendritic cell subsets have dif-
ferent origin and functions. Immunity. 2009;31(3):
502-12.
13. Ginhoux F, Liu K, Helft J, et al. The origin and de-
velopment of nonlymphoid tissue CD103 DCs.
J Exp Med. 2009;206(13):3115-30.
14. Fancke B, Suter M, Hochrein H, O’Keeffe M.
M-CSF: a novel plasmacytoid and conventional
dendritic cell poietin. Blood. 2008;111(1):150-159.
15. Kingston D, Schmid MA, Onai N, Obata-Onai A,
Baumjohann D, Manz MG. The concerted action
of GM-CSF and Flt3-ligand on in vivo dendritic
cell homeostasis. Blood. 2009;114(4):835-43.
16. Alvarez D, Vollmann EH, von Andrian UH.
Mechanisms and consequences of dendritic cell
migration. Immunity. 2008;29(3):325-342.
17. Ohl L, Mohaupt M, Czeloth N, et al. CCR7 gov-
erns skin dendritic cell migration under inflamma-
tory and steady-state conditions. Immunity. 2004;
21(2):279-288.
18. Fo¨rster R, Schubel A, Breitfeld D, et al. CCR7
coordinates the primary immune response by es-
tablishing functional microenvironments in sec-
ondary lymphoid organs. Cell. 1999;99(1):23-33.
19. MartIn-Fontecha A, Sebastiani S, Hopken UE,
et al. Regulation of dendritic cell migration to the
draining lymph node: impact on T lymphocyte
traffic and priming. J Exp Med. 2003;198(4):615-
621.
20. Yanagihara S, Komura E, Nagafune J, Watarai H,
Yamaguchi Y. EBI1/CCR7 is a new member of
dendritic cell chemokine receptor that is up-
regulated upon maturation. J Immunol. 1998;
161(6):3096-3102.
21. Sozzani S, Allavena P, D’Amico G, et al. Differen-
tial regulation of chemokine receptors during den-
dritic cell maturation: a model for their trafficking
properties. J Immunol. 1998;161(3):1083-1086.
22. Sallusto F, Schaerli P, Loetscher P, et al. Rapid
and coordinated switch in chemokine receptor
expression during dendritic cell maturation. Eur
J Immunol. 1998;28(9):2760-2769.
23. Dieu MC, Vanbervliet B, Vicari A, et al. Selective
recruitment of immature and mature dendritic
cells by distinct chemokines expressed in differ-
ent anatomic sites. J Exp Med. 1998;188(2):373-
386.
24. Chen Q, Fisher DT, Clancy KA, et al. Fever-range
thermal stress promotes lymphocyte trafficking
across high endothelial venules via an interleukin
6 trans-signaling mechanism. Nat Immunol.
2006;7(12):1299-1308.
25. Lapidot T, Dar A, Kollet O. How do stem cells find
their way home? Blood. 2005;106(6):1901-1910.
26. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Litt-
mann DR. Function of the chemokine receptor
CXCR4 in haematopoiesis and in cerebellar de-
velopment. Nature. 1998;393(6685):595-599.
27. Liles WC, Broxmeyer HE, Rodger E, et al. Mobili-
zation of hematopoietic progenitor cells in healthy
volunteers by AMD3100, a CXCR4 antagonist.
Blood. 2003;102(8):2728-2730.
28. Broxmeyer HE, Orschell CM, Clapp DW, et al.
Rapid mobilization of murine and human hemato-
poietic stem and progenitor cells with AMD3100,
a CXCR4 antagonist. J Exp Med. 2005;201(8):
1307-1318.
29. Me´ndez-Ferrer S, Frenette PS. Hematopoietic
stem cell trafficking: regulated adhesion and at-
traction to bone marrow microenvironment. Ann
N Y Acad Sci. 2007;1116:392-413.
30. Christopher MJ, Liu F, Hilton MJ, Long F, Link DC.
Suppression of CXCL12 production by bone mar-
row osteoblasts is a common and critical pathway
for cytokine-induced mobilization. Blood. 2009;
114(7):1331-1339.
31. Akira S, Uematsu S, Takeuchi O. Pathogen rec-
ognition and innate immunity. Cell. 2006;124(4):
783-801.
32. Iwasaki A, Medzhitov R. Toll-like receptor control
of the adaptive immune responses. Nat Immunol.
2004;5(10):987-995.
33. Chicha L, Jarrossay D, Manz MG. Clonal type I
interferon-producing and dendritic cell precursors
are contained in both human lymphoid and my-
eloid progenitor populations. J Exp Med. 2004;
200(11):1519-1524.
34. Sioud M, Floisand Y, Forfang L, Lund-Johansen F.
Signaling through toll-like receptor 7/8 induces
the differentiation of human bone marrow CD34
progenitor cells along the myeloid lineage. J Mol
Biol. 2006;364(5):945-954.
35. Sioud M, Floisand Y. TLR agonists induce the dif-
ferentiation of human bone marrow CD34 pro-
genitors into CD11c CD80/86 DC capable of
inducing a Th1-type response. Eur J Immunol.
2007;37(10):2834-2846.
36. Nagai Y, Garrett KP, Ohta S, et al. Toll-like recep-
tors on hematopoietic progenitor cells stimulate
innate immune system replenishment. Immunity.
2006;24(6):801-812.
37. Massberg S, Schaerli P, Knezevic-Maramica I,
et al. Immunosurveillance by hematopoietic pro-
genitor cells trafficking through blood, lymph, and
peripheral tissues. Cell. 2007;131(5):994-1008.
38. Welner RS, Pelayo R, Nagai Y, et al. Lymphoid
precursors are directed to produce dendritic cells
as a result of TLR9 ligation during herpes infec-
tion. Blood. 2008;112(9):3753-3761.
39. Onai N, Manz MG, Schmid MA. Isolation of com-
mon dendritic cell progenitors (CDP) from mouse
bone marrow. Methods Mol Biol. 2010;595:195-
203.
40. Tussiwand R, Onai N, Mazzucchelli L, Manz MG.
Inhibition of natural type I IFN-producing and den-
dritic cell development by a small molecule recep-
tor tyrosine kinase inhibitor with Flt3 affinity. J Im-
munol. 2005;175(6):3674-3680.
41. De Luca K, Frances-Duvert V, Asensio MJ, et al.
The TLR1/2 agonist PAM(3)CSK(4) instructs
commitment of human hematopoietic stem cells
to a myeloid cell fate. Leukemia. 2009;23(11):
2063-74.
42. Panopoulos AD, Watowich SS. Granulocyte
colony-stimulating factor: molecular mechanisms
of action during steady state and ‘emergency’
hematopoiesis. Cytokine. 2008;42(3):277-288.
43. Arbone´s ML, Ord DC, Ley K, et al. Lymphocyte
homing and leukocyte rolling and migration are
impaired in L-selectin-deficient mice. Immunity.
1994;1(4):247-260.
44. Cheong C, Matos I, Choi JH, et al. Microbial
stimulation fully differentiates monocytes to DC-
SIGN/CD209() dendritic cells for immune T cell
areas. Cell. 2010;143(3):416-429.
45. Sallusto F, Lanzavecchia A. Monocytes join the
dendritic cell family. Cell. 2010;143(3):339-340.
46. Akashi K, Traver D, Miyamoto T, Weissman IL. A
clonogenic common myeloid progenitor that gives
rise to all myeloid lineages. Nature. 2000;
404(6774):193-197.
47. Karsunky H, Inlay MA, Serwold T, Bhattacharya D,
Weissman IL. Flk2 common lymphoid progenitors
possess equivalent differentiation potential for the B
and T lineages. Blood. 2008;111(12):5562-5570.
4840 SCHMID et al BLOOD, 3 NOVEMBER 2011  VOLUME 118, NUMBER 18 only.
For personal use at UNIVERSITAETSSPITAL on November 25, 2011. bloodjournal.hematologylibrary.orgFrom 
